| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f810a690f8da94c9aaedc2645ca09090 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0529
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-37247
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7282
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-7264 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36064
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36139 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-372
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-374
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-00 |
| filingDate |
2016-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3e5f4827353ebf00e1148ba3c6c7e59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c0e9a4f5ef30f66cb8d69df4deedac5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_682db90c709ac72e1aad5515dbf77398
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82fa06d89ce82eb3e5ddcf1ae56d31ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2935e1a3937510535c89615c5028cf90 |
| publicationDate |
2018-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10130813-B2 |
| titleOfInvention |
Seizure onset classification and stimulation parameter selection |
| abstract |
A neurostimulation system senses electrographic signals from the brain of a patient, extracts features from the electrographic signals, and when the extracted features satisfy certain criteria, detects a neurological event type. A mapping function relates the detected neurological event type to a stimulation parameter subspace and a default stimulation parameter set where the values of the stimulation parameters define an instance of stimulation therapy for the patient. The decision whether to implement a stimulation parameter subspace or a default stimulation parameter set may be informed by integrating other information about a state of the patient. A stimulation parameter subspace or stimulation parameter set may optimized by testing it against various thresholds until certain effectiveness criteria is satisfied. The neurological event type may be one of several electrographic seizure onset types. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I765432-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021194821-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11697020-B2 |
| priorityDate |
2015-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |